Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...

In this video, Shikha Saxena, MD, attending physician of the division of pulmonary and sleep medicine at the Children's ...

What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...

Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic and treatable lung disease that touches nearly every family in America. It ...

Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

U.S. Rep. Kweisi Mfume (D-Md.-7) and Sen. Angela Alsobrooks (D-Md.) are teaming up on a new push to provide relief to those suffering from chronic lung conditions. Both members of Congress have put ...

Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...